Doubling third-stage oxytocin was associated with less postpartum haemorrhage after vaginal birth

Design

single-centre before-and-after quality-improvement study

Population

2,674 births with recorded quantitative blood loss, January to July 2024

Primary outcome

postpartum haemorrhage, quantitative blood loss 1,000 mL or more

Effect

14.3% to 11.2%, adjusted RR 0.77 (95% CI 0.64-0.93); vaginal births 8.5% to 5.2%, adjusted RR 0.60 (0.42-0.86); caesarean adjusted RR 0.89 (0.71-1.11)

A single American centre changed its third-stage oxytocin protocol from 30 units over the first hour followed by 3.6 units over the second, to 60 units over one hour, and compared 1,309 births before the change with 1,365 after, between January and July 2024. Implementation meant updating order sets, reprogramming infusion pumps and training staff. Only births with a recorded quantitative blood loss were analysed; placenta accreta spectrum and deliveries under 24 weeks were excluded.

Postpartum haemorrhage, defined as quantitative blood loss of 1,000 mL or more, fell from 14.3% to 11.2% (adjusted relative risk 0.77, 95% CI 0.64-0.93), with a small reduction in median blood loss (adjusted median difference -43 mL, 95% CI -72 to -14). The effect was confined to vaginal births, where haemorrhage fell from 8.5% to 5.2% (adjusted RR 0.60, 95% CI 0.42-0.86). At caesarean there was no reduction (23.4% against 21.8%, adjusted RR 0.89, 95% CI 0.71-1.11).

This is a before-and-after quality-improvement comparison, not a randomised trial, and everything that changes over six months in a busy unit changes with it - including the attention that a new haemorrhage protocol brings. But the intervention is a dose change in a drug already hanging on every delivery, and the mechanism is straightforward. In Indian units where the third stage is commonly managed with 10 to 20 units in a litre, this is a prompt to look at what the protocol actually delivers in the first hour rather than to copy 60 units across.

• Check what your third-stage protocol delivers in the first hour, in units, not in bag concentration
• If you change the dose, change the order set and the pump programming together - the study's effect depends on the infusion actually running as written
• Expect the benefit at vaginal birth; at caesarean, the answer lies elsewhere
• Keep quantitative blood loss measurement in place, or you will not be able to tell whether the change worked
• Watch for the known dose-related effects - hyponatraemia with large volumes, and hypotension with rapid administration

Why it matters

The drug is already running; the question is whether the dose in your protocol is the one that was studied.

Don't overread it

A before-and-after quality-improvement comparison cannot separate the dose change from everything else that improved alongside it.

The statistics, in plain English

An adjusted relative risk of 0.77 means about a quarter fewer haemorrhages; in absolute terms 14.3% to 11.2%, so roughly 32 women treated for one haemorrhage avoided. The caesarean confidence interval (0.71-1.11) crosses 1.0, which means no effect was shown there - not that the effect is smaller. The median blood loss difference of 43 mL is statistically solid and clinically trivial on its own, which tells you the benefit sits in the tail of the distribution rather than in the average delivery.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.